Virginia Silvari

445 total citations
18 papers, 358 citations indexed

About

Virginia Silvari is a scholar working on Internal Medicine, Geriatrics and Gerontology and Emergency Medical Services. According to data from OpenAlex, Virginia Silvari has authored 18 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Internal Medicine, 4 papers in Geriatrics and Gerontology and 4 papers in Emergency Medical Services. Recurrent topics in Virginia Silvari's work include Venous Thromboembolism Diagnosis and Management (5 papers), Patient Safety and Medication Errors (4 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Virginia Silvari is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (5 papers), Patient Safety and Medication Errors (4 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Virginia Silvari collaborates with scholars based in Ireland, Italy and Finland. Virginia Silvari's co-authors include Chiara Costa, R. De Pasquale, Stefania Catania, Maria Paola Germanò, Valeria D’Angelo, Salvatore Catania, J.J.A. Heffron, A. Trovato, Antonietta Melchini and Johanna Haglund and has published in prestigious journals such as SHILAP Revista de lepidopterología, Environmental Science & Technology and Journal of Agricultural and Food Chemistry.

In The Last Decade

Virginia Silvari

16 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Virginia Silvari Ireland 7 144 98 70 66 59 18 358
Min Cheol Pyo South Korea 13 143 1.0× 184 1.9× 51 0.7× 48 0.7× 49 0.8× 25 457
Janet Piloto Cuba 7 131 0.9× 90 0.9× 54 0.8× 85 1.3× 84 1.4× 12 377
Annu Arora India 13 179 1.2× 190 1.9× 49 0.7× 42 0.6× 45 0.8× 20 513
Darko Grujičić Serbia 12 119 0.8× 144 1.5× 56 0.8× 115 1.7× 92 1.6× 38 396
Amal Ramadan Egypt 12 118 0.8× 128 1.3× 49 0.7× 104 1.6× 28 0.5× 20 371
Samarjit Jana India 11 101 0.7× 169 1.7× 33 0.5× 52 0.8× 52 0.9× 13 423
Tarek M. Heikal Egypt 12 192 1.3× 44 0.4× 76 1.1× 36 0.5× 28 0.5× 16 351
Felix M. Kluxen Germany 14 108 0.8× 102 1.0× 137 2.0× 53 0.8× 110 1.9× 45 541
A.A. Khalaf Egypt 11 158 1.1× 52 0.5× 119 1.7× 36 0.5× 36 0.6× 14 445
Rasha A. Al-Eisa Saudi Arabia 10 115 0.8× 53 0.5× 55 0.8× 27 0.4× 26 0.4× 33 344

Countries citing papers authored by Virginia Silvari

Since Specialization
Citations

This map shows the geographic impact of Virginia Silvari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia Silvari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia Silvari more than expected).

Fields of papers citing papers by Virginia Silvari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia Silvari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia Silvari. The network helps show where Virginia Silvari may publish in the future.

Co-authorship network of co-authors of Virginia Silvari

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia Silvari. A scholar is included among the top collaborators of Virginia Silvari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia Silvari. Virginia Silvari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Burnett, Allison, et al.. (2025). Antithrombosis stewardship across the care spectrum: optimizing transitions in venous thromboembolism. Journal of Thrombosis and Haemostasis. 24(3). 866–876.
2.
Laaksonen, Raisa, et al.. (2024). Medication Safety in Intensive Care Settings across Europe – Focus Group Discussions. Research in Social and Administrative Pharmacy. 20(2). 226–226. 1 indexed citations
3.
Amigoni, Angela, et al.. (2024). Medication safety strategies in European adult, paediatric, and neonatal intensive care units: a cross-sectional survey. European Journal of Hospital Pharmacy. 32(2). 113–120. 1 indexed citations
5.
Laaksonen, Raisa, et al.. (2024). Patient safety culture and medication safety in European intensive care units: a focus group study. European Journal of Hospital Pharmacy. 32(3). 209–219.
6.
Silvari, Virginia, et al.. (2023). Value of hospital anticoagulation stewardship programme: A systematic review. SHILAP Revista de lepidopterología. 14. 100158–100158. 6 indexed citations
7.
Silvari, Virginia, et al.. (2017). Venous Thromboembolism - Risk Assessment Tool and Thromboprophylaxis Policy: A National Survey.. PubMed. 110(1). 499–499. 1 indexed citations
8.
Lester, Laeben, et al.. (2017). Hospital Acquired Thrombosis (HAT) Prevention in an Acute Hospital; A Single Centre Cross-Sectional Study.. PubMed. 110(4). 547–547. 4 indexed citations
9.
Silvari, Virginia, et al.. (2017). Incidence of Hospital Acquired Thrombosis (HAT) in a Tertiary Care Hospital.. PubMed. 110(4). 542–542. 3 indexed citations
10.
Healy, David A., Stig Hellebust, Virginia Silvari, et al.. (2011). Using a pattern recognition approach to link inorganic chemical fingerprints of ambient PM2.5–0.1 with in vitro biological effects. Air Quality Atmosphere & Health. 5(1). 125–147. 7 indexed citations
11.
Costa, Chiara, Virginia Silvari, Antonietta Melchini, et al.. (2008). Genotoxicity of imidacloprid in relation to metabolic activation and composition of the commercial product. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 672(1). 40–44. 75 indexed citations
12.
Norström, Karin, Johan Eriksson, Johanna Haglund, Virginia Silvari, & Åke Bergman. (2006). Enantioselective Formation of Methyl Sulfone Metabolites of 2,2‘,3,3‘,4,6‘-Hexachlorobiphenyl in Rat. Environmental Science & Technology. 40(24). 7649–7655. 24 indexed citations
13.
Silvari, Virginia, Johanna Haglund, Dag Jenssen, et al.. (2005). Reaction-kinetic parameters of glycidamide as determinants of mutagenic potency. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 580(1-2). 91–101. 14 indexed citations
14.
Haglund, Johanna, Virginia Silvari, Eddy L. Esmans, & Margareta Törnqvist. (2005). Cobalamin as an analytical tool for analysis of oxirane metabolites of 1,3-butadiene: Development and validation of the method. Journal of Chromatography A. 1119(1-2). 246–250. 17 indexed citations
15.
Costa, Chiara, et al.. (2005). In vitro evaluation of oxidative damage from organic solvent vapours on human skin. Toxicology in Vitro. 20(3). 324–331. 52 indexed citations
16.
Costa, Cinzia, Salvatore Catania, & Virginia Silvari. (2004). [Genotoxicity and activation of organophosphate and carbamate pesticides by cytochrome P450 2D6].. PubMed. 25 Suppl(3). 81–2. 6 indexed citations
17.
Costa, Chiara, et al.. (2003). Cytotoxicity evaluation after coexposure to perchloroethylene and selected peroxidant drugs in rat hepatocytes. Toxicology in Vitro. 18(1). 37–44. 6 indexed citations
18.
Germanò, Maria Paola, R. De Pasquale, Valeria D’Angelo, et al.. (2002). Evaluation of Extracts and Isolated Fraction from Capparis spinosa L. Buds as an Antioxidant Source. Journal of Agricultural and Food Chemistry. 50(5). 1168–1171. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026